HLA-DRB1 and myeloid sarcoma: According to our previous data, patients with disease onset ≤ 15 years showed complete absence of the HLA-DRB1*16 allele, while those with disease onset 16–19 years old presented with a lower HLA-DRB1*11 allele frequency compared both to the pediatric- and the adult-onset MS group [38].